EcoDrugPlus

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSMOCG00000002665
Gene Symbol: LOC101996843
3 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 1-Like 1

Ensembl ID : ENSMOCG00000008709
Gene Symbol: AOC1L1
1 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 1-Like 3

Ensembl ID : ENSMOCG00000016661
Gene Symbol: AOC1L3
1 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSMOCG00000016609
Gene Symbol: AOC3
3 Cross references
321 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSMOCG00000015189
Gene Symbol: APCS
3 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMOCG00000019286
Gene Symbol: APP
3 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSMOCG00000001177
Gene Symbol: AR
2 Cross references
276 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSMOCG00000007296
Gene Symbol: AGTR1
2 Cross references
195 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSMOCG00000008234
Gene Symbol: AGTR2
3 Cross references
191 Possible Orthologues:

Angiotensin-Converting Enzyme

Ensembl ID : ENSMOCG00000017839
Gene Symbol: LOC101982560
3 Cross references
93 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSMOCG00000001855
Gene Symbol: APLNR
3 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSMOCG00000022720
Gene Symbol: APH1A
3 Cross references
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).